REINSURANCE GROUP OF AMERICA INC
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| For the years ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Cash flows from operating activities | |||
| Net income | $902 | $517 | $1,170 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Change in operating assets and liabilities: | |||
| Accrued investment income | (99) | (111) | (15) |
| Premiums receivable and other reinsurance balances | (537) | (249) | (117) |
| Deferred policy acquisition costs | (490) | (311) | (160) |
| Reinsurance ceded receivable balances | (209) | 61 | 131 |
| Future policy benefits, other policy claims and benefits and other reinsurance balances | 4,142 | 793 | 3,720 |
| Deferred income taxes | 211 | 67 | 53 |
| Funds withheld payable | 49 | (63) | 82 |
| Other assets and other liabilities, net | 68 | 255 | (138) |
| Amortization of net investment premiums, discounts and other | (127) | (71) | (54) |
| (Income) loss from limited partnerships and real estate joint ventures | (181) | (331) | (419) |
| Investment related (gains) losses, net | 481 | 539 | (567) |
| Future policy benefits remeasurement (gains) losses | (62) | 291 | 567 |
| Market risk benefits remeasurement (gains) losses | (10) | 10 | (58) |
| Depreciation and amortization expense | 41 | 38 | 43 |
| Gain on sale of businesses | — | (2) | (11) |
| Other, net | (135) | (90) | (45) |
| Net cash provided by operating activities | 4,044 | 1,343 | 4,182 |
| Cash flows from investing activities | |||
| Sales of fixed maturity securities available-for-sale | 8,195 | 10,558 | 12,142 |
| Purchases of fixed maturity securities available-for-sale | (12,647) | (16,531) | (18,071) |
| Maturities of fixed maturity securities available-for-sale | 967 | 906 | 887 |
| Sales of equity securities | 1 | 7 | 30 |
| Purchases of equity securities | (5) | (15) | (22) |
| Principal payments on mortgage loans | 436 | 963 | 991 |
| Cash invested in mortgage loans | (1,280) | (1,314) | (1,155) |
| Deposits in (withdrawals from) funds withheld at interest | 352 | (36) | (67) |
| Sales of limited partnerships and real estate joint ventures | 474 | 710 | 498 |
| Purchases of limited partnerships and real estate joint ventures | (551) | (700) | (648) |
| Sales of short-term investments | 353 | 317 | 410 |
| Purchases of short-term investments | (601) | (528) | (185) |
| Maturities of short-term investments | 187 | 131 | 146 |
| Change in other invested assets | 102 | (140) | 547 |
| Proceeds from sale of businesses, net of cash transferred of $1 and $43 | — | 7 | 19 |
| Purchase of businesses, net of cash acquired of $53 | — | — | (156) |
| Other, net | (49) | (23) | 6 |
| Net cash used in investing activities | (4,066) | (5,688) | (4,628) |
| Cash flows from financing activities | |||
| Dividends to stockholders | (219) | (205) | (194) |
| Repayment of collateral finance and securitization notes | — | (181) | (208) |
| Proceeds from long-term debt issuance, net | 890 | 690 | 494 |
| Principal payments of long-term debt | (428) | (403) | (403) |
| Purchases of treasury stock | (227) | (81) | (99) |
| Change in cash collateral for derivative positions and other arrangements | 603 | 230 | 31 |
| Change in deposit asset on reinsurance | 227 | (44) | 91 |
| Deposits on investment-type policies and contracts | 2,860 | 5,705 | 1,729 |
| Withdrawals on investment-type policies and contracts | (3,628) | (1,365) | (1,421) |
| Net change in noncontrolling interest | — | 90 | — |
| Net cash provided by financing activities | 78 | 4,436 | 20 |
| Effect of exchange rate changes on cash | (13) | (112) | (34) |
| Change in cash and cash equivalents | 43 | (21) | (460) |
| Cash and cash equivalents, beginning of period | 2,927 | 2,948 | 3,408 |
| Cash and cash equivalents, end of period | $2,970 | $2,927 | $2,948 |
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the years ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Supplemental disclosures of cash flow information: | |||
| Interest paid | $217 | $163 | $160 |
| Income taxes paid, net of refunds | 298 | 129 | 368 |
| Non-cash investing activities: | |||
| Transfer of invested assets | 2,006 | 618 | 1,798 |
| Non-cash financing activities: | |||
| Non-cash deposits on reinsurance | 2,792 | — | 1,581 |
| Purchase of a business: | |||
| Assets acquired, excluding cash acquired | — | — | 847 |
| Liabilities assumed | — | — | (691) |
| Sale of businesses: | |||
| Assets disposed, net of cash transferred | — | (6) | (512) |
| Liabilities disposed | — | 1 | 504 |
Notes to consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Note 1 BUSINESS AND BASIS OF PRESENTATION
Business
Reinsurance Group of America, Incorporated (“RGA”) is an insurance holding company that was formed on December 31, 1992. RGA and its subsidiaries (collectively, the “Company”) engage in providing traditional reinsurance, which includes individual and group life and health, disability, and critical illness reinsurance. The Company also provides financial solutions, which includes longevity reinsurance, asset-intensive products, primarily annuities, financial reinsurance, capital solutions and stable value products.
Reinsurance is an arrangement under which an insurance company, the reinsurer, agrees to indemnify another insurance company, the ceding company, for all or a portion of the insurance risks underwritten by the ceding company. Reinsurance is designed to:
(i)reduce the net amount at risk on individual risks, thereby enabling the ceding company to increase the volume of business it can underwrite, as well as increase the maximum risk it can underwrite on a single risk;
(ii)enhance the ceding company’s financial strength and surplus position;
(iii)stabilize operating results by leveling fluctuations in the ceding company’s loss experience; and
(iv)assist the ceding company in meeting applicable regulatory requirements.
Basis of Presentation
The consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates include those used in determining, premiums receivable, future policy benefits, incurred but not reported claims, income taxes, valuation of investments and investment impairments, and valuation of embedded derivatives and market risk benefits. Actual results could differ materially from the estimates and assumptions used by management.
The accompanying consolidated financial statements include the accounts of RGA and its subsidiaries, all of which are wholly owned, and any variable interest entities where the Company is the primary beneficiary. The Company evaluates variable interest entities in accordance with the general accounting principles for Consolidation. Entities in which the Company has significant influence over the operating and financing decisions but are not required to be consolidated are reported under the equity method of accounting. Intercompany balances and transactions have been eliminated.
There were no subsequent events that would require disclosure or adjustments to the accompanying consolidated financial statements through the date the consolidated financial statements were issued.
Standards Issued and Implemented
In the first quarter of 2023, the Company adopted Accounting Standards Update (“ASU”): ASU 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”). ASU 2018-12 updates certain requirements for the accounting for long-duration insurance contracts.
Cash flow assumptions and measuring liability for future policy benefits – ASU 2018-12 requires the Company to review its cash flow assumptions at least annually and update, if necessary, with the impact recognized in net income in the period of the change. The liability for future policy benefits includes required adjustments at the cohort level to cap the net premium ratio at 100% and eliminate negative reserves.
Upon adoption, an adjustment was recorded to retained earnings as a result of capping the net premium ratio at 100% and eliminating negative reserves on certain issue year cohorts.
Discount rate – The discount rate assumption is prescribed by ASU 2018-12 as an upper-medium (low credit risk) fixed-income yield and is required to be updated every quarter. The change in the liability as a result of updating the discount rate assumption is recognized in other comprehensive income (loss) (“OCI”).
Upon adoption, an adjustment was recorded to accumulated other comprehensive income (loss) (“AOCI”) as a result of remeasuring in force contract liabilities using the current upper-medium grade fixed income instrument yields as of the date of transition. The adjustment reflects the difference between discount rates locked-in at contract inception versus current discount rates at transition.
Deferred policy acquisition costs and similar balances – Deferred policy acquisition costs (“DAC”) and other capitalized costs such as unearned revenue should be amortized on a constant level or straight-line basis over the expected term of the contracts.
Upon adoption, an adjustment was recorded to AOCI for the removal of cumulative adjustments to DAC associated with unrealized investment gains and losses previously recorded in accumulated other comprehensive income (loss).
Market risk benefits – Market risk benefits, which are contracts or contract features that provide protection to the policyholder from capital market risk and expose the Company to other-than-nominal capital market risk, are measured at fair value. The periodic change in fair value is recognized in net income with the exception of the periodic change in fair value related to the liability’s instrument-specific credit risk, which is recognized in OCI.
Upon adoption, an adjustment was recorded to retained earnings for the difference between the fair value and carrying value of the contracts at the transition date, excluding changes in the instrument-specific credit risks, and an adjustment to AOCI for the cumulative effect of changes in the instrument-specific credit risk between contract issue date and transition date.
Change in Certain Segment Allocations
Investment income for each segment has been adjusted to reflect the impacts of adopting ASU 2018-12 and due to an update to the Company’s internally developed economic capital model. Internal excess capital charges, included in each segment’s policy acquisition costs and other insurance expenses, were also updated as a result of adopting ASU 2018-12 and updates to the Company’s internally developed economic capital model. These changes did not impact the recognition or presentation of investment income or policy acquisition costs and other insurance expenses in the consolidated financial statements.
Note 2 SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS
The following table includes the Company’s significant accounting policies with references to the notes providing additional information on such policies and critical accounting estimates related to such policies.
| Accounting Policy | Page |
|---|---|
| Insurance Related Activities: | |
| Premium and Fee Revenue and Receivable Recognition | 99 |
| Future Policy Benefits | 100 |
| Interest-Sensitive Contract Liabilities and Policyholder Account Balances | 101 |
| Unpaid Claims and Claim Expense – Short-Duration Contracts | 102 |
| Market Risk Benefits | 102 |
| Deferred Policy Acquisition Costs | 103 |
| Reinsurance Ceded Receivables | 103 |
| Investments | 103 |
| Derivative Instruments | 106 |
| Fair Value Measurements | 108 |
| Income Tax | 108 |
| Other Accounting Policies | 109 |
Insurance Related Activities
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.